Skip to main content

Table 3 Radical treatment within 1 year of being diagnosed with prostate cancer according to the Cambridge Prognostic Group (CPG)

From: Risk stratification for prostate cancer management: value of the Cambridge Prognostic Group classification for assessing treatment allocation

 Patients (n)Radical Tx (%)Adj. RR95% CIP
CPG
 110,9631236 (11.3)0.230.18–0.30< 0.001
 213,5876580 (48.4)1  
 394496263 (66.3)1.441.36–1.53 
 412,82810,112 (78.8)1.691.32–2.15 
 515,16011,118 (73.3)1.701.37–2.11 
Age group (years)
 < 6089875195 (57.8)1 < 0.001
 60–6924,34314,843 (61.0)0.910.82–1.01 
 70–7923,97214,073 (58.7)0.780.70–0.88 
 ≥ 8046851198 (25.6)0.310.22–0.44 
Number of comorbidities (RCS Charlson score)
 047,96027,921 (58.2)1 0.011
 194605159 (54.5)0.950.73–1.24 
 ≥ 245672229 (48.8)0.850.51–1.44 
Socioeconomic deprivation status (5th of national distribution)
 1 (least deprived)14,8258525 (57.5)1 0.267
 214,5718309 (57.0)0.980.92–1.04 
 313,0277428 (57.0)0.980.88–1.08 
 410,6666067 (56.9)0.970.49–1.76 
 5 (most deprived)88984980 (56.0)0.930.60–1.60 
Ethnicity
 White57,58132,838 (57.0)1 0.908
 Non-white44062471 (56.0)0.980.87–1.13